Assessment of the Psychological Impact of the COVID19 (SARS-CoV-2) Pandemic on Patients With Chronic Inflammatory Rheumatism

NCT04723407 | Unknown

• 1 other identifier: 87RI20_0062 /RICOVID19
• Study Type: observational
• Target: 950
• Locations: 1 country
• Sites: 1

Brief Summary

Patients with chronic inflammatory rheumatism (RIC) or autoimmune diseases, rheumatoid arthritis and spondyloarthritis, are regularly monitored in consultation as part of a "treat to target" strategy with rapid adaptation of treatments to the activity of their disease. according to French recommendations. They are treated with immunosuppressive drugs: disease-modifying treatments with very often methotrexate, associated with biotherapies or targeted therapies (JAK inhibitors) They can also be treated transiently or over the long term with corticosteroids. These treatments expose them to greater infectious risks, especially with regard to COVID19. The objective is on the one hand to assess the impact of the Covid 19 pandemic on general state of health of these patients and the evolution of their disease and on the other hand to prioritize the optimal care of these patients by including in the context of maintaining the pandemic reduction rules, modern telemedicine technologies.

Conditions

Rheumatism

Outcome Measures

Primary Outcomes (1)

• post-traumatic stress

  Presence or absence of post-traumatic stress disorder due to the COVID19 pandemic assessed by the Post-traumatic stress disorder Check-list version DSM-5 (PCL-5)

  Day 1

Study Arms (2)

Exposed patients

Those who had the management strategy implemented by the service during confinement

Other: questionnaires

Unexposed patients

Those who could not benefit from this strategy

Other: questionnaires

Interventions

questionnaires OTHER

Questionnaire completion

Exposed patients; Unexposed patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All patients with chronic inflammatory rheumatism followed in the rheumatology department of the CHU de Limoges

You may qualify if:

• All patients with chronic inflammatory rheumatism followed in the rheumatology department of the CHU de Limoges.

You may not qualify if:

• Patients who object to the use of their data.

Sponsors & Collaborators

• University Hospital, Limoges: lead

Study Sites (1)

Département de Rhumatologie

Limoges, France

Location

MeSH Terms

Conditions

Rheumatic Diseases

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Musculoskeletal Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Central Study Contacts

Philippe BERTIN, MD

CONTACT

0555056871; philippe.bertin@chu-limoges.fr

Corinne TRAPY

CONTACT

corinne.trapy@chu-limoges.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 22, 2021
• First Posted: January 25, 2021
• Study Start: February 1, 2021
• Primary Completion: January 1, 2022
• Study Completion: March 1, 2022
• Last Updated: January 26, 2021

Record last verified: 2021-01

Locations

FR (1)